Back to Scanner
RLAY
NASDAQCANSLIMRS 99Score 75Relay Therapeutics, Inc.
HealthcareBiotechnology$1.92B6 setups passing
$12.54
+16.4% ($1.77)
+9.1% from 52W High
P/E (TTM)
-6.70
Fwd P/E
—
PEG
—
Analyst Upside
+43.5%
EPS Growth
—
Gross Margin
91.2%
ROE
-43.2%
D/E
0.06
Div Yield
0.0%
Avg Volume
2.4M
Price Chart
Key Levels
SMA 200
$6.45
SMA 50
$9.24
Price
$12.54
52W High
$11.49
Target
$18.00
Setup Radar
6/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst